Objectives: Juvenile polyps involving the stomach are uncommon. Massive gastric juvenile polyposis is even rarer.
Results: All patients had anemia; four had hypoalbuminemia. The polyps were composed predominantly of dilated crypts lined by columnar epithelium and abundant edematous stroma with mixed inflammatory infiltrates. One patient had a poorly differentiated adenocarcinoma, arising in juvenile polyp-associated intraepithelial neoplasia. A second patient had a well-differentiated intramucosal adenocarcinoma arising in a juvenile polyp with high-grade dysplasia. Three of our cases had polyposis restricted to the stomach. Six (66.6%) had loss of SMAD4 immunoreactivity, making them subject to severe bleeding and hypoproteinemia, as well as developing severe dysplasia or adenocarcinoma.
Conclusions: SMAD4 immunohistochemstry is a helpful ancillary diagnostic test in cases of suspected juvenile polyposis syndrome involving the stomach.
Although isolated juvenile polyps of the gastrointestinal tract are quite common in children, juvenile polyposis is an uncommon syndrome. 1, 2 Established diagnostic criteria for juvenile polyposis require the presence of more than five colonic juvenile polyps, juvenile polyps throughout the gastrointestinal tract, or juvenile polyps with a family history of juvenile polyposis. 3 However, the clinical presentation of this syndrome and the distribution of its constituent mucosal lesions are diverse. Because the histologic features of juvenile polyps overlap with those of other more commonly encountered entities, particularly in atypical sites (ie, gastric hyperplastic polyps), the incidence of juvenile polyposis may be underestimated. 3, 4 While isolated juvenile polyps are generally thought to be benign, the lesions of juvenile polyposis have Upon completion of this activity you will be able to:
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considerable malignant potential. The cumulative lifetime risk for colorectal adenocarcinoma in syndromic patients is 39%. 5 Although less is known about the risk of extracolonic malignancy, the incidence of developing upper gastrointestinal carcinoma in individuals with gastric polyps in one of the largest reported kindred (n ¼ 117) was 21%. 6 The syndrome is transmitted in an autosomal dominant manner with variable penetrance, and approximately 50% of cases are familial. 5, 7 Germline mutations in SMAD4, BMPR1A, or other TGFB/ BMP pathway genes are identified in approximately half of cases 8 ; the remainder have no known molecular cause. Congenital anomalies are present in a minority of patients. 7 Because a substantial number of juvenile polyposis cases are sporadic or lack characteristic lesion distributions or extraintestinal manifestations, the diagnosis must be established by careful pathologic evaluation of the polyps themselves.
Hamartomatous polyps of juvenile polyposis syndrome typically have a spherical shape with a smooth surface, although larger examples are often multilobated, and some juvenile polyps may have a more villiform architecture. Histologically, the polyps contain numerous dilated crypts supported by abundant edematous stroma that contains a mixed inflammatory infiltrate. While no morphologic features definitively separate syndromic from nonsyndromic lesions, selected genetic alterations may correlate with morphologic variation of juvenile polyps. 9 Gastric juvenile polyps are reportedly uncommon. 10, 11 Cases of juvenile polyps massively carpeting the stomach (massive gastric juvenile polyposis [MGJP]) Image 1 , Image 2 , and Image 3 are even rarer. Herein we describe the clinicopathologic features of nine cases of MGJP, including three patients with involvement limited to the stomach. Because germline SMAD4 mutations are linked to polyps and cancers of the upper gastrointestinal tract 12, 13 and loss of SMAD4 expression by immunohistochemistry mirrors SMAD4 mutation status, 14 we evaluated the frequency of SMAD4 loss in nonmalignant portions of these polyps, hypothesizing that SMAD4 immunohistochemistry Image 1 Gastrectomy specimen from a 40-year-old woman with massive gastric juvenile polyposis (diagnosed at age 31 years). The mucosal surface is covered with innumerable polyps.
Image 2 Gastric mucosal surface of a patient with gastric polyposis. The stomach was placed in water for this photograph, highlighting the villous papillary architecture of the numerous polyps.
Image 3 Cross section through the gastric wall of a 52-yearold man with gastric juvenile polyposis. Polyps measured up to 7 cm in maximum dimension and covered nearly the entire stomach with focal sparing of the lesser curvature.
may be a useful diagnostic adjunct in cases of suspected juvenile polyposis.
Materials and Methods
Nine cases with MGJP were retrospectively identified in the pathology files of four participating large referral centers. The studies were approved at each institutional review board. Six patients underwent gastric resection. H&E-stained tissue sections from biopsy samples and resection specimens were reviewed before inclusion in the study to confirm the diagnosis. Medical records, including demographic data, medical history, family history of gastric or intestinal polyps and/or cancer, and laboratory data were reviewed.
A single representative block from the cases whenever available was selected for SMAD4 immunohistochemistry. For these studies, 4-mm-thick formalin-fixed, paraffinembedded tissue sections were prepared. All stains were performed on the Bond III automated platform (Leica Microsystems, Buffalo Grove, IL). The anti-SMAD4 antibody was used at a dilution of 1:200 (Santa Cruz Technologies, Santa Cruz, CA). Heat-induced epitope retrieval employed EDTA/Tris buffer (pH 9) at 100 C for 20 minutes on the automated platform. Bond Polymer Refine Detection, a biotin-free polymer, was used as the detection system (DS9800; Leica Microsystems). Appropriate positive and negative controls were used throughout the procedures. Loss of SMAD4 staining in the polyp was qualitatively defined when there was reduced or absent cytoplasmic or nuclear SMAD4 staining in any nonmalignant portion of the polyps compared with the normal epithelium and inflammatory cells in the surrounding lamina propria.
Results

Clinical Features
Five men and two women, aged 20 to 60 years at the time of initial diagnosis, had confirmed juvenile polyposis of the stomach (confirmed by virtue of a positive family history or by coexisting juvenile polyps of the colon; Table 1 . Two men, aged 56 to 61 years at initial diagnosis, had probable juvenile polyposis of the stomach Table 2 . Intermittent abdominal pain was the most common presenting symptom, experienced by seven patients. Two patients had hematemesis, later determined to be caused by gastric outlet obstruction from massive polyposis involving the gastric antrum. All nine patients were anemic at presentation, and four had a history of anemia prior to having gastrointestinal symptoms. Four patients were hypoalbuminemic. Three patients previously underwent colon resections for juvenile polyposis.
Of the nine patients, only two had a confirmed family history of juvenile polyposis syndrome. Several had firstand second-degree relatives with "multiple" colonic polyps, and one had a father diagnosed with colon cancer at age 51 years. One patient's mother underwent gastrectomy, reportedly for a "parasitic" infection, but the details regarding this are not known. The endoscopic appearance was variable, ranging from several pedunculated polyps of the gastric antrum to massive carpeting of the gastric body and antrum by innumerable sessile or pedunculated polyps. In the two patients with fewer polyps, involvement was limited to the antrum, and thickened gastric folds were noted in the surrounding antral mucosa. In one of these patients, a large pedunculated antral polyp prolapsed into the duodenum. Three patients also had one or more duodenal polyps.
After the diagnosis of gastric juvenile polyposis was established, seven patients underwent complete or partial gastrectomy, either to control upper gastrointestinal tract symptoms, anemia, or protein loss or in response to dysplastic changes found in the polyps during surveillance biopsy. Of these, two patients had low-grade dysplasia, and three had gastric adenocarcinoma.
The first of the patients with gastric carcinoma was a 51-year-old man who had a total colectomy for multiple juvenile polyps 19 years prior to his most recent presentation. Gastric juvenile polyps with low-grade dysplasia were discovered at age 48 years during routine surveillance Image 4A , and three years later, gastric signet ring cell adenocarcinoma was found in association with marked dysplastic changes of the adjacent foveolar epithelium Image 4B .
The second patient with gastric carcinoma was a 26-year-old woman who had sought treatment prior to the time of gastrectomy for intermittent crampy lower abdominal and left periumbilical pain. She was found to have multiple colonic and gastric juvenile polyps. Seventeen months after the initial presentation, colonoscopy revealed a number of polyps in the ascending colon, including a 5-cm juvenile polyp with low-grade dysplasia and approximately 100 smaller juvenile polyps, some of which also had low-grade dysplasia. Biopsy specimens from the gastric cardia showed a well-differentiated adenocarcinoma arising in a juvenile polyp. Partial gastroesophagectomy was performed, revealing high-grade dysplasia and intramucosal adenocarcinoma in one of innumerable juvenile polyps Image 5 . Gastric
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Image 4 A, Gastric polyp with dysplasia from a 51-year-old man with gastric and intestinal juvenile polyposis (diagnosed at age 32 years). This section shows features of low-grade dysplasia, with slightly elongated, enlarged, hyperchromatic nuclei that maintain normal nuclear polarity (H&E, Â100). B, Gastric carcinoma, diffuse type, involving gastric juvenile polyp. Note the presence of an extensive signet ring cell population expanding the lamina propria (H&E, Â200). polyps recurred less than 1 year following the resection, and a completion gastrectomy was performed. The third patient with gastric carcinoma sought treatment emergently at approximately age 40 years with massive upper and lower gastrointestinal bleeding. There was no known family history. Endoscopy showed a large ulcerated gastroesophageal junction polyp, later confirmed to be invasive carcinoma, as well as several gastric, small bowel, and colonic juvenile polyps with low-and high-grade dysplasia.
One patient (patient 6) developed severe diarrhea postoperatively and was diagnosed with Clostridium difficile colitis. This was successfully treated with antibiotics. The patient with poorly differentiated gastric carcinoma (patient 1) developed a postoperative abdominal wound abscess, pneumonia, and pleural effusion and subsequently died approximately 1 month after surgery. In this series, he is the only patient known to have died.
Pathologic Findings
In the seven patients who underwent gastric resection, the resection specimens revealed gastric polyps ranging in number from 40 to several hundred and in size from 0.3 to 7 cm (Images 1 and 2) . The polyps were concentrated in the gastric body and antrum, and in most of the patients, the morphology of the polyps was remarkably homogeneous. As shown in Image 6 , the polyps appeared to represent expansions of the upper gastric mucosa (particularly the foveolar zone), without disruption of the underlying fundic or antral glands. While foveolar hyperplasia was present in the mucosa flanking some of the polyps, the polypoid lesions themselves were stroma rich without marked surface foveolar proliferation. The polyp stroma was edematous and contained an unevenly distributed lymphocytic inflammatory infiltrate. Glands within the polyps were largely recapitulations of the surface and foveolar epithelium without significant atypia. At the base of some of the polyps, parietal cells were admixed with mucinous epithelium. There was no evidence of an arborizing elaboration of the muscularis mucosa. Given this constellation of features, the polyps were considered hamartomatous in type, with features of juvenile polyposis including a relative expansion of epithelial and stromal elements of the upper lamina propria, relatively smooth surface contours without significant surface hyperplasia, and an absence of neoplastic transformation.
Two of the patients also had characteristic features of low-grade dysplasia (nuclear crowding, hyperchromasia, and slight nuclear elongation) focally involving the gastric juvenile polyps but without high-grade dysplasia or carcinoma. Also, as previously noted, three patients developed carcinoma within the gastric polyps. In one of these, the gastric resection specimen contained a 26-cm mass centered in the distal portion of the stomach, including the distal body and antrum. The mass was predominantly composed of innumerable pedunculated polyps with long stalks and a smooth surface. One side of the mass was more solid, however, and adjacent to this area, there was a 4-cm nodule with central ulceration, distortion of the underlying gastric wall, and focal adhesions of the omentum along portions of the serosal surface. Histologic evaluation of this region revealed an invasive poorly differentiated adenocarcinoma extending into the submucosa, as well as abundant lymphatic and vascular invasion with satellite nodules in the subserosal adipose tissue and associated involvement of the visceral serosa. The morphologic patterns of the invasive carcinoma were complex; the lesion included areas of poorly differentiated carcinoma with features of diffuse-type adenocarcinoma, areas of moderate-to well-differentiated intestinal-type adenocarcinoma, and a region of intramucosal signet ring cell carcinoma located in an adjoining polypoid lesion. The configuration and cellular constituents of the polypoid lesions in all sampled sites were most consistent with juvenile polyps. In at least two areas, glandular neoplasia was accompanied by metaplastic and neoplastic squamous mucosa as well. In this patient, concurrent biopsy specimens of the duodenum showed multiple juvenile polyps, with associated foveolar metaplasia and no evidence of dysplasia.
Immunohistochemistry
Results of immunohistochemistry for SMAD4 are included in Table 1 and Table 2 . Six (66.6%) patients had loss Image 5 High-grade dysplasia/intramucosal adenocarcinoma arising in a gastric juvenile polyp from a 26-year-old woman. The nuclei are pleomorphic and enlarged and have lost their normal polarity, resulting in a "jumbled" appearance (H&E, Â200).
of expression of SMAD4 in the nondysplastic epithelium Image 7 , and three patients had retained SMAD4 expression throughout the entire lesion sampled for immunohistochemical analysis.
Discussion
Juvenile polyposis syndrome is rare and clinical presentations are varied. 1, 15 Several patterns of juvenile polyposis have been described, including infantile juvenile polyposis syndrome, juvenile polyposis coli (polyps limited to colon), and generalized juvenile polyposis syndrome (polyps throughout the colon, small bowel, and stomach). 16 Infantile juvenile polyposis is often fatal before age 2 years due to medical complications, including protein-losing enteropathy, rectal bleeding, and anemia. Patients with juvenile polyposis coli or generalized juvenile polyposis have rectal bleeding and anemia later in adolescence or early adulthood or may be entirely asymptomatic. Germline mutations into two genes, SMAD4 and BMPR1A, are responsible for approximately 50% to 60% of cases of juvenile polyposis syndrome, 12, 13 and patients with SMAD4 mutations have a higher frequency of gastric polyposis and a greater risk of gastric carcinoma. 13 To our knowledge, this represents the first clinicopathologic description of a series of patients with massive gastric involvement to evaluate SMAD4 immunostaining in the setting of histologically confirmed gastric juvenile polyposis. Application of current diagnostic criteria when presumed juvenile polyps are encountered only in the stomach is problematic primarily because of the morphologic similarities among gastric hyperplastic polyps, juvenile polyps, and other hamartomatous polyps, although the frequent lack of family history in these patients may also complicate definitive diagnosis. Diagnostic considerations may therefore include other syndromic gastric polyps, including, but not limited to, those of Peutz-Jeghers syndrome and Cronkhite-Canada syndrome. 10 Peutz-Jeghers polyps can generally be distinguished by their arborizing architecture, with branching cores of smooth muscle dividing the lamina propria between hyperplastic-appearing glands. The polyps of Cronkhite-Canada syndrome, which are essentially indistinguishable histologically from juvenile polyps, can be diagnosed only in the presence of corroborating clinical features, such as alopecia, nail atrophy, or hyperpigmentation. 10 Another clue may be the abnormal intervening mucosa seen in Cronkhite-Canada syndrome polyps but not in juvenile polyposis syndrome. Ménétrier disease (hypertrophic gastropathy) may also be a consideration. Clinically, one of the patients in this study was suspected to have Ménétrier disease due to the hypertrophic appearance of the gastric folds endoscopically and to the presence of a protein-losing enteropathy. Again, the preservation of at least some normal intervening gastric mucosa in cases of juvenile polyposis may help distinguish from Ménétrier disease. 10 Ménétrier disease also exhibits generalized involvement of the gastric body with relative sparing of the antrum, while juvenile polyps in the stomach show a tendency toward antral predominance. 17 Other nonsyndromic gastric polyps may enter the differential diagnosis particularly for patients with fewer gastric lesions, perhaps incidentally discovered earlier in the disease course. Hyperplastic polyps were the most common alternative consideration in our series, with one patient carrying a diagnosis of multiple hyperplastic polyps for a year prior to revision to MGJP. Hyperplastic polyps, like juvenile polyps, are most commonly located in the antrum. 17 Compared with hyperplastic polyps, juvenile polyps are generally more extensive and densely distributed and have more abundant inflamed stroma and less foveolar hyperplasia than hyperplastic polyps. 1 The SMAD4 gene is a tumor suppressor gene that codes for the SMAD4 protein of the transforming growth factor b superfamily signaling pathway. SMAD4 mutations are present in 15% to 20% of patients with juvenile polyposis syndrome, 12, 18 and the frequency of gastric polyposis in SMAD4 mutation carriers is 73%. 13 Aberrant SMAD4
immunostaining in juvenile polyps occurs exclusively in patients with SMAD4 mutations; however, SMAD4 staining is lost in only about half of known mutation carriers, according to one study. 14 We noted aberrant loss of expression in 66.6% of patients with MGJP, without any significant correlation between SMAD4 status, presence/absence of dysplasia or carcinoma, and other clinical variables. However, we noted that the older patients in our series (older than 40 years) uniformly exhibited loss of SMAD4 expression in their polyps, which mirrors a previously noted trend that SMAD4 mutation carriers are older at presentation than other patients with juvenile polyposis syndrome. 13 We also did not note any association of SMAD4 immunostaining with morphologic subtypes of juvenile polyps or degree of epithelial proliferation, as others have described. 9 SMAD4
retention in patients with juvenile polyposis does not exclude the possibility of a germline SMAD4 mutation, 14 although in these patients, other causal mutations may be implicated in polyp formation and neoplastic progression. One limitation
A B
Image 7 Loss of expression of SMAD4 by immunohistochemistry in the lesional epithelium in a polyp (A, low magnification; B, high magnification). Nuclear and cytoplasmic staining in the epithelial cells lining normal gastric pits or inflammatory cells in the lamina propria serve as internal control.
of our study is that we do not have details of mutational testing available for comparison. However, given the excellent specificity of aberrant SMAD4 immunoexpression to identify patients with the SMAD4 germline mutation, we believe it is a useful ancillary test in patients with gastric polyps suspected of being syndromic, which may not be easily characterized as juvenile polyps on initial histologic evaluation.
As recently as 1975, some authors held the view that juvenile polyps did not have a recognizable premalignant potential. 19 While a juvenile polyp is generally regarded as a hamartoma, it is now generally established that juvenile polyposis is potentially a premalignant condition. 3, 5, 20 In our series, three of nine patients developed gastric adenocarcinoma. The histologic patterns and degree of differentiation were variable, with one patient having a diffuse, poorly differentiated gastric adenocarcinoma and two others with well-differentiated gastric adenocarcinoma arising in a background of dysplasia within a juvenile polyp. In perhaps the most pertinent clinicopatholgic study extant in the literature, Hizawa et al 1 identified 41 patients with juvenile polyposis dominantly involving the stomach, including 12 patients who had involvement solely of the stomach. There was a female predominance among patients with stomachlimited disease but no difference in other features, including age at initial presentation, family history, clinical presentation, and incidence of associated malignancy. Of the 12 patients with stomach-limited disease, neoplastic changes were found in four patients, including three (25%) with adenocarcinoma and one with low-grade dysplasia. The rate of gastric carcinoma in the remainder of the patients having more generalized gastrointestinal involvement was similar (7/29 or 24%). The most striking clinical feature observed was anemia (89%), which is quite similar to our experience. One of our patients had a family history of a father with gastric juvenile polyposis, a second patient had a brother with colonic juvenile polyposis, and a third patient had a family history of unspecified colon polyps and colon carcinomas in several relatives. Reports in the literature show that up to 20% to 50% of cases of juvenile polyposis are familial 21 and inherited in an autosomal dominant manner. Recent advances have been made in understanding the molecular basis for this disease. A linkage analysis of a large kindred established an association with a gene mapping to chromosome 18q21.1, a region containing both the DCC and DPCR/SMAD4 tumor suppressor genes. 22 Shortly thereafter, germline truncating mutations in DPCR/SMAD4 were found to be responsible for a subset of juvenile polyposis disease. 8 DPCR/SMAD4 mutations may only account for up to 35% to 60% of patients with juvenile polyposis in North America, but in 2001, another gene-this one encoding bone morphogenetic protein receptor 1A (BMPR1A)-accounted for a subset of juvenile polyposis cases 23 and may account for as many as 40% of patients lacking DPCR/SMAD4 mutations. 24 Yet, a substantial number of cases are still caused by as yet undefined genetic mutations. Correlation between genotype and phenotype generally has been poor, but a recent investigation of 29 unrelated patients with juvenile polyposis revealed the presence of massive gastric polyposis in four of seven patients with DPCR/ SMAD4 mutations, in contrast to a lack of such severe disease in patients with BMPR1A mutations or without identified mutations. 12 Although additional investigation is needed, this suggests the possibility of genotype-phenotype correlation in MGJP. 13 In conclusion, MGJP is a rare yet important entity that has implications for genetic counseling, endoscopic surveillance, and possible surgical resection. Severe bleeding, dysplastic change, and adenocarcinoma can arise when multiple juvenile polyps are present in the stomach. Because patients harboring germline SMAD4 mutations so frequently have gastric involvement, SMAD4 immunohistochemistry is a helpful ancillary diagnostic test in cases of suspected juvenile polyposis syndrome involving the stomach, with the caveat that a subset of true syndromic lesions will not exhibit loss of this marker.
